The advanced lung cancer inflammation index (ALI) is a composite prognostic index that incorporates body mass index (BMI), serum albumin, and neutrophil-to-lymphocyte ratio (NLR), reflecting both nutritional and systemic inflammatory states. The gene discussed is ALB; the disease is lung cancer.